Applications of Genomic Technology in Disease Outcome Prediction

Dear Colleagues,

This Special Issue focuses on the enormous volume of genetic information obtained from technologies that can provide insights into the genetic factors influencing the development and progression of disease.

By analyzing genomic data in conjunction with clinical information, researchers and healthcare professionals can identify the genetic markers associated with specific diseases and their outcomes. These markers may include specific gene mutations, gene expression patterns, or variations in the genome. Studying these markers enables patients who are at risk of developing certain diseases or experiencing poor treatment responses to be identified.

The application of genomic technology in disease outcome prediction has the potential to revolutionize personalized medicine. By employing this approach, physicians can develop targeted treatment plans based on an individual's genetic profile, leading to more effective treatments and improved patient outcomes. Additionally, disease risk prediction can aid in early detection and prevention efforts, as individuals identified as high-risk can undergo regular monitoring or preventative interventions.

However, challenges remain in translating genomic data into clinically actionable information. The interpretation of genomic data requires expertise in bioinformatics, statistical analysis, and clinical medicine. Furthermore, ethical considerations must be taken into account, such as protecting patient privacy and ensuring adequate informed consent.

Continued research in this field holds promise for a future in which the application of genomic technology will enhance the accuracy of disease outcome prediction, leading to personalized, targeted treatments that improve patient care and outcomes.

Prof. Dr. Sulev Koks
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• genomic technology
• disease outcome prediction
• genetic analysis
• genetic variations
• genome-wide association studies (GWAS)
• genetic risk factors
• biomarkers
• genetic risk score
• next-generation sequencing (NGS)
• rare genetic variants
• personalized medicine
• treatment strategies.